Immune Isolating Device With Improved Diffusion

TECHNOLOGY NUMBER: 2024-096
Technology No. 2024-096

OVERVIEW

Dual-layer hydrogel capsule for immune-isolated ovarian grafts

  • Enhances nutrient diffusion and mechanical resilience.
  • Useful for ovarian graft health, fertility preservation, and transplantation.


BACKGROUND

The need for effective ovarian tissue grafting is critical for fertility preservation, especially for cancer patients and those undergoing treatments that affect ovarian function. Traditional approaches have faced challenges, such as immune rejection and insufficient nutrient diffusion, compromising graft viability. Previously, single-layer hydrogel capsules have been used, but their utility was limited by poor nutrient diffusion and mechanical stability under physiological conditions. These shortcomings necessitate an improved method to ensure the long-term health and functionality of ovarian grafts. Innovations in biomaterials and tissue engineering offer new opportunities to address these challenges by enhancing both the mechanical resilience and biological functionality of the encapsulating materials.


INNOVATION

Researchers have developed a dual-layer hydrogel capsule incorporating thermosensitive gelatin microgels to enhance immune isolation and nutrient diffusion for ovarian graft tissue. These microgels are embedded into the outer shell during crosslinking and melt upon implantation, forming micron-scale pores that improve nutrient flow. In vitro tests have demonstrated increased small molecule diffusion and enhanced mechanical resilience to strain with this new design. Ongoing mouse studies aim to evaluate the status, biocompatibility, and functionality of the capsules over both short-term and long-term periods. Real-world applications include improved methods for ovarian tissue grafting, offering better outcomes in fertility preservation and transplantation medicine, with potential to expand to other types of tissue grafts requiring immune isolation and enhanced nutrient access.


ADDITIONAL INFORMATION

REFERENCES

Day, J. R., Flanagan, C. L., David, A., Hartigan-O’Connor, D. J., Garcia de Mattos Barbosa, M., Martinez, M. L., Lee, C., Barnes, J., Farkash, E., Zelinski, M., Tarantal, A., Cascalho, M., & Shikanov, A. (2023). Encapsulated allografts preclude host sensitization and promote ovarian endocrine function in ovariectomized young rhesus monkeys and sensitized mice. Bioengineering, 10(5), 550. https://doi.org/10.3390/bioengineering10050550

Day, J. R., David, A., Barbosa, M. G. d. M., Brunette, M. A., Cascalho, M., & Shikanov, A. (2019). Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice. Scientific Reports, 9, Article 16567. https://doi.org/10.1038/s41598-019-53075-8


INTELLECTUAL PROPERTY

US10918673B2 "Immunoisolation device"

US11786560B2 "Immunoisolation device"


RELATED TECHNOLOGY


  • expand_more mode_edit Inventor (3)
    Ariella Shikanov
    Margaret Brunette
    Delaney Sinko
  • expand_more cloud_download Supporting documents (1)
    Product brochure
    Immune Isolating Device With Improved Diffusion.pdf
Questions about this technology?